This is the authors' abstract. We don't add key points for this paper.
G protein-coupled receptors (GPCRs) are the largest family of cell surface receptors in humans. The binding and dissociation of ligands tunes the inherent conformational flexibility of these important drug targets towards distinct functional states. Here we show how to trigger and resolve protein-ligand interaction dynamics within the human adenosine A2A receptor. For this, we designed seven photochemical affinity switches derived from the anti-Parkinson’s drug istradefylline. In a rational approach based on UV/Vis spectroscopy, time-resolved absorption spectroscopy, differential scanning fluorimetry and cryo-crystallography, we identified compounds suitable for time-resolved serial crystallography. Our analysis of millisecond-scale dynamics revealed how trans-to-cis isomerization shifts selected istradefylline derivatives within the binding pocket. Depending on the chemical nature of the ligand, interactions between extracellular loops 2 and 3, acting as a lid on the binding pocket, are disrupted and rearrangement of the orthosteric binding pocket is invoked upon ligand dissociation. This innovative approach provides insights into GPCR dynamics at the atomic level, offering potential for developing novel pharmaceuticals. G protein-coupled receptors (GPCRs) are critical drug targets that undergo conformational changes upon ligand binding. Here, authors developed photochemical switches for the adenosine A2A receptor and followed ligand dissociation using time-resolved crystallography.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Glover et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: